Results for all races are now on our results page.
Coverage of the race on the front page story in the Press Democrat...read more
Hincapie Star Attraction in Breakaway Ride...read the story in Cycling News
MERCHANDISE BLOW-OUT SALE
Free shipping on all orders over $100
To place an order, call 714-978-1528 or email Info@PacificSportsLLC.com
Cycling enthusiasts and fans are invited to participate in "Breakaway Ride presented by Specialized,” two riding events held in conjunction with the upcoming 2010 Amgen Tour of California professional cycling race set for May 16-23, 2010. Both rides will be held in April 2010 to raise funds for Amgen's Breakaway from Cancer® initiative, which aims to raise awareness of the continuum of resources available from prevention to education, and patient care to advocacy and financial support. The Breakaway from Cancer nonprofit partners include the Prevent Cancer Foundation, Cancer Support Community (formerly The Wellness Community), Patient Advocate Foundation and National Coalition for Cancer Survivorship.
Each ‘Breakaway Ride’ gives cycling enthusiasts the opportunity to ride the actual route of the 2010 Amgen Tour of California. Three distances will be offered for each ride to accommodate various skill levels; the longest distance covers the same route that the pros will ride (an entire stage). Riders will be chip timed and supported, with a maximum of 3,500 riders per event.
The two Breakaway Ride dates are:

A portion of each rider’s entry fee will be donated to Breakaway from Cancer’s charitable partners. Additionally, riders will have the opportunity to earn gifts and prizes by raising additional funds for the Breakaway from Cancer charitable partners. Prize packages include VIP experiences at the 2010 Amgen Tour of California and a top-of-the-line Specialized Tarmac or Roubaix bike for each ride’s top fundraiser.
The Official Jerseys of the Breakaway Ride:


BREAKAWAY RIDES PRESENTED BY SPECIALIZED TO OFFER AMATEUR CYCLISTS OPPORTUNITY TO RIDE 2010 AMGEN TOUR OF CALIFORNIA ROUTES...read the press release.






